The Phase I/II Oasis trial is asssing the safety and efficacy of OsteoAdapt SP, an implant made from synthetic material, according to a Nov. 19 news release shared with Becker’s. The implant also has a uniquely designed protein to encourage bone growth.
David Schwartz, MD, performed the first procedure in the clinical trial, and M. Craig McMains, MD, completed the second case.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
